12:00 AM
Nov 22, 1999
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Biocompatibles, Abbott sales and marketing update

Abbott gained exclusive multi-year U.S. distribution rights to BII's BiodivYsio coated coronary stents. BII will file for U.S....

Read the full 66 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >